Shenyang Center for Disease Control and Prevention of key departments of the Department of Liver Diseases is responsible for the Shenyang area of liver disease publicity, prevention, treatment, testing and technical guidance and training work, is currently one of the larger scale of liver disease treatment centers in Liaoning Province, has a number of liver disease experts, professors with rich clinical experience, and year-round invitation to members of the Chinese Medical Association Society of Liver Diseases, the National Hepatitis Research and Treatment Center, the chief experts, masters, doctoral tutors, chief physicians should be consulted. The specialists, masters, doctoral supervisors and chief physicians who have high attainments in liver diseases are invited to visit the clinic all the time, and are entitled to the special governmental allowance issued by the State Council.
Shenyang Disease Prevention and Control Liver Disease Center is the first in the province to introduce the hepatitis B virus gene (dna) detection system from Finland, the international advanced 66-hole fluorescence PCR detection system and FS1000 microfluorescence detector, the United States medisonSA-6000C three-dimensional digital Doppler color ultrasound diagnostic instrument, FS919 type DNA amplification quantitative detection system, Multiskan MK3 Enzyme Labeling Instrument and other professional testing equipment. The introduction of advanced treatment method of low-frequency pulse therapy, so that many patients with hepatitis to get rid of long-term medication and huge medical costs, only a few hospitals in the country to introduce, the therapeutic effect is very significant. However, due to the limitations of equipment and technical factors, in the short term, the treatment technology can not be fully popularized in the country.
Using the domestic leading hepatitis B (HBV) virus gene (DNA) detection system, its main role: case analysis, quantitative analysis of the HBV virus, virus type analysis, virus variation analysis, HBV drug resistance test, drug efficacy assessment. It breaks the traditional blind use of interferon treatment, blind use of antiviral drugs such as Lamivudine. Hepatitis B HBV-DNA genetic testing system can comprehensively understand the condition, so that it can achieve the scientific use of drugs, scientific development of treatment programs, especially for the use of anti-hepatitis B virus drugs, to avoid blind use of drugs and reduce viral drug resistance. Through the clinical analysis of a large number of cases, the current use of this hepatitis B HBV-DNA genetic testing system, there is a combination of the condition, combined with different hepatitis B patients specific situation specific analysis, targeted treatment.